In vivo neuronal gene editing via CRISPR–Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer’s disease-Reference-Cited by-同舟云学术

In vivo neuronal gene editing via CRISPR–Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer’s disease

Published:2019-03-11 Issue:4 Volume:22 Page:524-528
ISSN:1097-6256
Container-title:Nature Neuroscience
language:en
Short-container-title:Nat Neurosci

Author:

Park Hanseul,Oh Jungju,Shim Gayong,Cho Byounggook,Chang Yujung,Kim Siyoung,Baek Soonbong,Kim Hongwon,Shin Jeain,Choi Hwan,Yoo Junsang,Kim Junyeop,Jun Won,Lee Minhyung,Lengner Christopher J,Oh Yu-Kyoung,Kim Jongpil^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Neuroscience

Link

http://www.nature.com/articles/s41593-019-0352-0.pdf

Reference23 articles.

1. Selkoe, D. J. Science 298, 789–791 (2002).

2. Thies, W. H. Alzheimers Dement. 11, 727–729 (2015).

3. Small, D. H., Mok, S. S. & Bornstein, J. C. Nat. Rev. Neurosci. 2, 595–598 (2001).

4. Fukumoto, H., Cheung, B. S., Hyman, B. T. & Irizarry, M. C. Arch. Neurol. 59, 1381–1389 (2002).

5. Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Cold Spring Harb. Perspect. Med. 1, a006189 (2011).

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders;Current Gene Therapy;2025-02

2. CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment;CNS & Neurological Disorders - Drug Targets;2024-12

3. Emerging paradigms in Alzheimer's therapy;European Journal of Pharmacology;2024-10

4. Application of novel CRISPR tools in brain therapy;Life Sciences;2024-09

5. Modeling APOE ε4 familial Alzheimer’s disease in directly converted 3D brain organoids;Frontiers in Aging Neuroscience;2024-08-09